Chen, Feng <br/><br/>
Camptothecin suppresses NRF2-ARE activity and sensitises hepatocellular carcinoma cells to anticancer drugs.  [electronic resource] 

 -  British journal of cancer  Nov 2017 
 - 1495-1506 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1532-1827 
<br/><br/><label>Standard No.: </label>10.1038/bjc.2017.317  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Camptothecin--pharmacology<br/>Carboxylic Ester Hydrolases--metabolism<br/>Carcinoma, Hepatocellular--drug therapy<br/>Drug Resistance, Neoplasm--drug effects<br/>Female<br/>Humans<br/>Liver Neoplasms--drug therapy<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Middle Aged<br/>NF-E2-Related Factor 2--biosynthesis<br/>Xenograft Model Antitumor Assays